Classical-like Ehlers-Danlos syndrome type 2

Get in touch with RARE Concierge.

Contact RARE Concierge

Synonyms: AEBP1-related EDS | AEBP1-related Ehlers-Danlos syndrome | Classical-like EDS type 2 | clEDS type 2

A rare systemic disease characterized by generalized joint hypermobility with recurrent joint dislocations redundant and hyperextensible skin with poor wound healing and abnormal scarring easy bruising and osteopenia/osteoporosis. Additional manifestations include hypotonia delayed motor development foot deformities prominent superficial veins in the chest region vascular complications (like mitral valve prolapse and aortic root dilation) hernias dental anomalies scoliosis and facial dysmorphisms (like high palate micrognathia narrow palate). Mode of inheritance is autosomal recessive.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version February 2026

Newly diagnosed with
Classical-like Ehlers-Danlos syndrome type 2?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

The Chandler Project

The Chandler Project brings awareness and shines a light on transformative research surrounding achondroplasia and other skeletal dysplasias by offering support to a global community and network of patients, parents, and caregivers seeking information on scientific discoveries, pharmaceutical advancements and surgical treatment options.

Zebra CARE Initiative

To bring Charity, Access, Research, and Education (CARE) through and beyond the rare disease, disabled, and medically complex communities for a more inclusive and accessible medical system.

website Location: Local

Don't see your organization here. Let us know here.

Clinical Trials

For a list of clinical trials in this disease area, please click here.